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Robotic computer system develops 
high­skill ‘techno surgeons’ 
Just 15 months after four 
highly sophisti cated robot­
assisted da Vinci Surgical 
Systems were introduced to 
South Africa (SA), nine local 
urologists are now ‘flying’ the ZAR23  mil­
lion devices ‘solo’, while another ten are 
being mentored on the revolutionary robot­
ic­assisted laparoscopic tool.
The surgical robotic system (four 
surgeon-controlled operating ‘arms’) 
was introduced via Earth Medical to 
four private hospitals in Cape Town, 
Johannesburg and Pretoria and gives 
highly skilled, appropriately trained 
specialists greater vision, precision and 
control during procedures, going beyond 
the flexibility and rotational capabilities 
of the human hand. It has also highlighted 
innate hospital/doctor and funder tensions 
in providing expensive but effective high-
tech medical equipment while maintaining 
viable patient funding. However, and 
perhaps most importantly, the da Vinci 
system has exposed an ‘elephant in the 
room’ – the internationally aberrant 
overuse by SA specialists of brachy therapy 
as a treatment modality for prostate cancer 
(73% above the global norm). Funded as 
a prescribed minimum benefit by medical 
aids (as is open prostatic surgery and 
traditional keyhole surgery), brachytherapy 
(the relatively quick and highly strategic 
placement of a radioactive ‘pellet’ at the 
prostate cancer site) allows urologists to 
conduct twice as many procedures a day 
as is possible with open or laparoscopic 
surgery. 
Top academic compares 
treatments – and backs 
the device
Top academic and urologist Prof. André van 
der Merwe of Stellenbosch University conducted 
an in-depth comparative litera ture study of the 
available treatment modalities for prostatic cancer 
in SA. He concluded that brachytherapy ‘should 
be reduced to international proportions (i.e. to 
7% from the SA usage figure of 80%)’, with robotic 
laparoscopic surgery a ‘valuable tool’ in helping 
achieve this. In his paper, he neutrally comments 
that ‘should the caring physician benefit from one 
of the many options, then he might be biased 
in the manner he counsels the newly diagnosed 
patient’, adding that a powerful differential 
exists between the urologist and the patient in 
consultations after a diagnosis of prostate cancer 
is made. Izindaba interviews with well-placed 
expert sources gleaned anecdotal evidence that 
some urologists often fail to discuss the pros 
and cons of various therapeutic options with 
their patients (most have very similar eventual 
outcomes), pushing brachytherapy and often not 
mentioning the sometimes appropriate strategy 
of ‘watchful waiting’ and active surveillance. Dr 
Jonathan Broomberg, CEO of SA’s largest open 
medical aid, Discovery Health, said it was ‘critical’ 
that doctors discuss all available treatment options 
and the associated risks and benefits with their 
patients. Patient choice and decisions based on 
best evidence were ‘vital if we are to achieve better 
value in our healthcare system’.
Van der Merwe described robotic surgery 
in SA as ‘a major step forward in patient care’ 
and ‘the beginning of a new chapter in local 
healthcare’. He concluded that even though it 
is unfair to compare the early learning curve 
of robotic prostatectomy with the established 
learning curve of open and laparoscopic radical 
prostatectomy, ‘one could confidently say that 
the oncological (and urinary/sexual) outcomes 
are similar or better (using the da Vinci system), 
but definitely not worse’. Most importantly, 
properly performed, the camera-assisted 
robotic procedure is the international gold 
standard in minimally invasive surgery, halving 
recovery times and enabling unprecedented 
vision, precision and control (the 3-D HD 
camera image is magnified 10 times).
As good as its operator
The da Vinci, while an amazing piece of 
technology, is still a doctor-driven device. 
Training is taken very seriously, with doctors 
taught via a console-driven simulator where a 
90% pass rate on 35 different test areas is required 
for hands-on proficiency. They are then sent 
to Belgium for live porcine practice. Following 
Prof. André van der Merwe.
IZINDABA
436      June 2015, Vol. 105, No. 6
that, a highly experienced international urolo-
gist is flown out to SA to mentor the local 
urologists on patients via a ‘buddy system’. 
This involves two local urologists conducting 
a daily prostatectomy each for 10 days under 
supervision, the one local urologist observing 
and the other operating, and then swapping 
around in morning and afternoon sessions. This 
is obviously not teaching the urologist how to do 
a prostatectomy, but how to apply the da Vinci 
technology best to benefit from its advantages. 
The mentor may take over the console from 
time to time, just as a flying instructor would 
if potential safety concerns arise. Only when 
he is satisfied that they can use it safely and 
proficiently does he sign them off and they can 
go solo. Mentors insist that all procedures are 
filmed via the internal camera and e-mailed to 
them for ongoing monitoring and feedback, 
and they are continually available for advice 
and guidance. The average training time to full 
proficiency can vary from surgeon to surgeon. 
Simulator and initial local training takes some 
45 hours and the overseas ‘wet lab’ training about 
16 hours, while the local mentored stint typically 
covers 12 - 15 cases. Depending on the surgeon’s 
skill levels and how quickly he or she gets the 
cases done, they may be spread out over between 
3 months and a year, depending on a number 
of logistical factors. Newly signed-off urologists 
are counselled about the critical importance of 
patient selection, with obese patients initially 
avoided at all costs.
Wider application 
imminent
If the hospital and its doctors follow the 
proper surgery protocols, operations are safe, 
reproducible and result in reduced compli-
cations, minimal blood loss and improved 
functional and oncological outcome. According 
to Earth Medical, the rigorous training pathway 
eliminates any ‘short cuts’. Future applications 
for da Vinci surgery in SA would include 
appropriate colorectal and gynaecological proce-
dures, and with over a year of successful use 
in prostatectomies, the intention is to move to 
other urological procedures including partial 
nephrectomies and and cystectomies. 
One local hospital manager who has 
overseen the da Vinci introductory phase is 
Hein Calitz, general manager of Durbanville’s 
Medi clinic Hospital. Quizzed on the health 
economics, Calitz said an entire operation 
cost about ZAR190 000 (including doctor and 
allied professionals’ fees), of which they could 
recover only about ZAR125 000 - 135 000 from 
some of the medical aids. However, certain 
medical aid schemes would only pay for open 
surgery and brachytherapy, flatly refusing to 
fund robotic surgery. ‘At present we’re writing 
that da Vinci medical aid payment shortfall off. 
We’re not recovering from the patient yet. We’re 
still crunching the numbers. It’s for now more 
important to do volumes to get the surgeons fully 
trained than worry about getting a better price 
than ZAR125K and/or the balance in patient 
co-payments.’ He intimated that over time, 
doctors would try and convince patients that it 
was worth their while to pay in the ZAR65 000 
shortfall, although this could be phased in with 
patients paying half of this amount for the 
next year. Calitz said that the robot system 
was as susceptible to advancing technology 
as any other computer device, so that within 
5  - 6 years it would probably need replacing. 
His hospital group had built ZAR40 000 into 
the overall procedure price to recover some 
of the equipment expense. Calitz said when 
Mediclinic motivated for higher medical aid 
payouts for its robotic prostatectomies, the 
medical aids’ response was that this would 
require an unrealistic increase in membership, 
or premium hikes, to make it financially viable. 
He said that punting procedure volumes, 
potentially improved surgical outcomes and 
vastly reduced patient recovery times cut no ice 
with medical aids, challenged as they already 
were by soaring new technology costs. 
Broomberg told Izindaba that Discovery 
Health had performed a detailed health 
economic analysis on the use of the da Vinci 
robotic system for prostatectomy. Based 
on this, they funded the da Vinci robotic 
prostatectomy up to a ‘defined rand limit’, which 
was currently at a 40 - 60% premium over 
the cost of the open prostatectomy procedure. 
‘Our analysis indicates that this premium is 
the maximum that can be justified in terms of 
the incremental benefit of the da Vinci system, 
and also represents a sufficient reimbursement 
to the hospitals for the cost of the device. 
We’ve agreed a full reimbursement arrangement 
with some hospitals, but unfortunately, other 
hospitals insist on charging patients a higher 
rate, resulting in co-payments for some patients.’
Koert Pretorius, CEO of Mediclinic, said his 
company viewed the da Vinci system as research 
and development and a way of exposing doctors 
to the best research and technology while 
giving patients access to the latest treatment 
modalities. ‘In principle we’re prepared to make 
a contribution in the introductory phase, it’s not 
just about money for us,’ he said.
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Case study: COPIC
COPIC is a doctors’ insurer based in Colorado, USA. They operate an in-house reporting system called the ‘Three Rs’ programme 
(Recognise, Respond, Resolve), where any doctor who has experienced an adverse outcome or had their patient express 
dissatisfaction with their care can contact a specifi c COPIC administrator to arrange their intervention. According to the 
COPIC website, the goals of the programme are ‘to maintain the physician-patient relationship, facilitate open and honest 
communication and disclosure, and reimburse the patient for related out-of-pocket medical expenses’.[1]
A series of interviews with patients who had participated in the programme revealed, tellingly, that: ‘When the communication 
with the physician was good, open, and honest, the outcome was viewed as an honest mistake. Patients referred to their 
outcomes under these circumstances as both forgivable and understandable. Conversely, when the communication was 
perceived as poor or non-existent, the same outcome was viewed as an error or negligence.’[2]
Of the 1 829 patients who had received reimbursement of their medical expenses through the programme, only 3.4% went on 
to make a claim against their doctor. While not offi  cially described as a complaints system, COPIC’s programme is an example of 
dissatisfaction handled eff ectively with a demonstrable eff ect on the likelihood of litigation.
1. www.callcopic.com/copic-services/safety-and-risk/Pages/3rs.aspx (accessed 7 October 2014).
2. Lembitz A. Litigation alternative: COPIC’s 3Rs program. AAOS Now 2010;4(9). www.aaos.org/news/aaosnow/sep10/managing7.asp (accessed 5 May 2015).
